BioLargo reports FY results
2026-03-06 04:32:24 ET
More on BioLargo
- BioLargo, Inc. (BLGO) Q4 2025 Earnings Call Transcript
- BioLargo anticipates 2026 as a transformative year with Clyra Medical commercialization and battery joint ventures
- Seeking Alpha’s Quant Rating on BioLargo
- Historical earnings data for BioLargo
- Financial information for BioLargo
Read the full article on Seeking Alpha
For further details see:
BioLargo reports FY resultsNASDAQ: BLGO
BLGO Trading
-1.54% G/L:
$0.166 Last:
20,271 Volume:
$0.1629 Open:



